Search

Your search keyword '"Parnetti L"' showing total 838 results

Search Constraints

Start Over You searched for: Author "Parnetti L" Remove constraint Author: "Parnetti L"
838 results on '"Parnetti L"'

Search Results

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

4. New insights into the genetic etiology of Alzheimer's disease and related dementias

5. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

7. The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design

8. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid

9. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

10. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

11. Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem)

13. New insights into the genetic etiology of Alzheimer's disease and related dementias

14. Clinical and biomarker profiling of prodromal Alzheimerʼs disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’

16. White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers

17. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

18. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

19. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

20. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

21. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis

22. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

23. Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study

24. High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease

25. Cross-sectional clinical, neuropsychological, neuroimaging, and neurophysiological characterization of mild cognitive impairment patients in WP5 PharmaCog/E-ADNI study: EP1105

26. 1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

29. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

30. LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS

31. Changes of olfactory tract in Parkinson’s disease: a DTI tractography study

32. Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease

33. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation

41. Time trends, frequency, characteristics and prognosis of short‐duration transient global amnesia

42. Italian consensus recommendations for a biomarker‐based aetiological diagnosis in mild cognitive impairment patients

47. Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker

Catalog

Books, media, physical & digital resources